
Brian Lee McClune DO
Hematologic Oncology
Associate Professor, Medicine, University of Utah
Join to View Full Profile
1950 Circle of Hope DrSalt Lake City, UT 84112
Phone+1 801-585-0100
Dr. McClune is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of TennesseeFellowship, Hematology and Medical Oncology, 2003 - 2006
- Johns Hopkins UniversityResidency, Internal Medicine, 2000 - 2003
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2000
Certifications & Licensure
- UT State License 2019 - 2026
- KS State License 2018 - 2020
- MN State License 2006 - 2018
- TN State License 2003 - 2011
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Autologous Transplant for Multiple Myeloma Start of enrollment: 2004 Apr 20
- Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) Start of enrollment: 2007 Aug 01
- Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Start of enrollment: 2006 Dec 19
- Join now to see all
Publications & Presentations
PubMed
- Patient Preferences on Clinical Decision Making in Multiple Myeloma.Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Katherine Berger, Ryan Winborg, Mason S Barnes
JCO Oncology Practice. 2025-07-24 - Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis.Kritika Yadav, Meera Mohan, Charlotte Wagner, Rajshekhar Chakraborty, Douglas Sborov
Leukemia. 2025-07-16 - Access barriers to hematopoietic stem cell transplantation and CAR T-cells in US.Maria Silvina Odstrcil Bobillo, Brian McClune, Daniel R Couriel
Leukemia & Lymphoma. 2025-07-06
Journal Articles
- Caution with Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple MyelomaBrian McClune, DO, JAMA Oncology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: